Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a Specialistglobalpharmacyplus.com, a Canada-based online pharmacy, was found to unlawfully sell unapproved and misbranded drugs to U.S. consumers in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), and 505(a)). The company's website offered drug products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19 without FDA approval or authorization, as well as unapproved versions of drugs subject to FDA Risk Evaluation and Mitigation Strategy (REMS) safety programs. The enforcement action was issued during the COVID-19 public health emergency declaration, when the FDA prioritized protecting consumers from unauthorized products making pandemic-related health claims.